Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by logical1234on Feb 20, 2002 1:11pm

284 Views

Post# 4795669

RE: What is the purpose of a cross transaction?

I there any reason that the brokers doing the cross have to disrupt the whole market to get the price down to where they want to do the cross? Why can't they just transact at the agreed price, and leave the rest of the market alone? Eg. if I want to sell to my sister at 30 cents cheaper, why can't I just do it, and not try to manipulate the whole market price first?

Bullboard Posts

Transportation technology stock secures second major contract in a week